Get started Log in

BIOBV — Biohit Oyj Share News

0.000.00%

Last trade - 00:00

HealthcareAdventurousMicro CapContrarian

Market Cap
€33.15m
Enterprise Value
€31.65m
Revenue
€15.73m

Brief: Biohit H1 Operating EBITDA Swings To Loss Of EUR 1.0 Mln
12/08/2020 07:37
Brief: Biohit 2020 Net Sales Now Seen To Decrease Compared To 2019
04/06/2020 16:04
Brief: Biohit To Convene Annual General Meeting At Later Stage
27/03/2020 16:28
Brief: Biohit H2 Operating EBITDA EUR 0.2 Million
19/02/2020 07:35
Brief: Biohit H1 Operative EBITDA Swings To Profit Of EUR 0.4 Mln
14/08/2019 07:34
Brief: Biohit Concludes Clinical Trials With Acetium
09/08/2019 13:50
Brief: Biohit Signs Distribution Agreement With Difar Distribuzione For Acetium Lozenge
17/04/2019 07:39
Brief: Biohit: Precision Health To Distribute Acetium Lozenge In Thailand
11/04/2019 07:51
Brief: Biohit: GastroPanel Validated As Predictor Of Gastric Cancer Risk In Multicenter Study
09/04/2019 07:45
Brief: Biohit: Satya Abadi Pharma To Distribute Acetium Lozenge In Indonesia
04/04/2019 07:37
Brief: Biohit H2 Operative EBITDA Down At EUR 0.0 Million
20/02/2019 07:33
Brief: Biohit Publishes Results From Comparison Study With ColonView-FIT
18/01/2019 07:35
Brief: Biohit: Results Of Migraine Study To Be Delayed
07/09/2018 13:04
Brief: Biohit And Retail Partner Sign Agreement For Distribution Of Acetium Lozenge
03/09/2018 08:09
Brief: Biohit H1 Operative EBITDA Loss At EUR 0.1 Million
22/08/2018 07:34
Brief: Biohit Oyj appoints Jukka Kainulainen as Chief Financial Officer
30/04/2018 23:48
Brief: ‍Biohit And Oriola Sign Agreement For Distribution Of Acetium Lozenge In Finland
12/03/2018 08:35
Brief: Biohit H2 Operating Loss Narrows To EUR 1.0 Million
28/02/2018 07:30
Brief: Biohit Signs Distribution Agreement For Norway
23/02/2018 08:00
Brief: Biohit CFO Leaves The Company
20/02/2018 07:30